Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

WellDyneRx

WellDyneRx
1990 FOUNDED
M&A STATUS
Buyout/LBO LATEST DEAL TYPE
3 FINANCING ROUNDS
Description

Provider of pharmacy prescription services. The company operates as a pharmacy benefit manager (PBM), providing full-service prescription drug management between patients and drug plans through a network of retail providers in addition to a mail order and specialty drug pharmacy. The company works with a retail network of 65,000 pharmacies throughout the United States.

Formerly Known As
RxWest
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Catalog Retail
Other Industries
Pharmaceuticals
Internet Retail
Primary Office
  • 500 Eagles Landing Drive
  • Lakeland, FL 33810
  • United States

+1 (800) 000-0000

WellDyneRx Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore WellDyneRx‘s full profile, request access.

Request full access to PitchBook

WellDyneRx Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore WellDyneRx‘s full profile, request access.

Request full access to PitchBook

WellDyneRx Executive Team (7)

Name Title Board
Seat
Contact
Info
Zachary Johnson President
Stephen Saft Chief Financial Officer & Chief Administrative Officer
Mark SantaCroce Chief Commercial Officer
Damien Lamendola Owner & Chief Executive Officer
Susan Cain Chief Operating Officer

1 Former Executive

You’re viewing 5 of 7 executives. Get the full list »